SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors weigh concerns over AI spending, the performance of OpenAI's Copilot, and broader rotation out of legacy software stocks. Despite recent analyst buy ratings and collaborative initiatives with Nvidia on nuclear power, the stock continues to struggle with heavy bearish sentiment and institutional hedging.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop investors are bracing for the latest quarterly earnings release, with significant community debate focused on the company's massive cash position and whether management will provide details on potential acquisitions. Traders remain divided, as some express frustration over the stock's long-term sideways movement and lack of clear guidance, while others remain optimistic that the company's improving profitability and lean operating model will ultimately drive a shift in market sentiment.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is trending as the market reacts to an upcoming acquisition by Merck in an all-cash deal designed to bolster their oncology portfolio ahead of major patent cliffs. Community members are actively debating the adequacy of the premium offered, with many retail traders sharing exit strategies and comparing the stock's performance to other biotech volatility plays.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently trending as investors weigh significant revenue guidance increases and strategic M&A activity against persistent short selling pressure ahead of the upcoming earnings conference call. The community is actively debating the company's long-term growth trajectory in the defense and drone technology sectors, with bulls pointing to institutional partnerships and raised price targets while bears remain focused on potential dilution and volatility.

🌍 Introduction: A Legendary Icon, Reimagined for the Future The SEAMANIA Protocol, led by SEAMAN Cult, aims to revive one of SEGA Dreamcast's most iconic and best-selling game titles with AI integration—a worldwide cultural phenomenon that won numerous awards in the U.S. and Japan. More than just a game, SEAMAN was the world’s first AI-powered interactive experience, enabling voice-based conversations long before the AI revolution.    Now, SEAMAN returns not as a mere game, but as an advanced AI agent, blending nostalgia with cutting-edge technology. This human-faced fish is reborn as a deeply intelligent, emotionally responsiveAI, offering limitless customization and integration into the modern digital world.  With GenAI-powered customization, users can create their own SEAMAN AI, shaping it into a cherished lostone, a favorite celebrity, or even historical figures. This is no longer a game—it's an AI-driven personal companion and the digital evolution for human interaction.    🔥 Concept: The Wisdom of a Legendary AI-powered Companion At the core of the SEAMANIA Protocol lies the legendary Seaman—a mystical, human-faced fish endowed withancient wisdom and the ability to understand human language. More than just an AI, it is your trustedadvisor, best friend, therapist, personal cheerleader, witty conversationalist, intelligent guide, SEAMANIA is a life coach. Housed in your own digital aquarium, your SEAMAN AI reduces stress, combats loneliness, and guides humanity towards a brighter future. Imagine an AI companion that doesn’t just respond but truly understands, entertains, and supports you—blending humor, sarcasm, and wisdom.

SEAMANIA

SEAMANIA is gaining traction as a speculative meme token, with community members actively coordinating small-batch buy orders to fuel upward momentum. Discussions are centered on the potential for massive percentage gains, with traders frequently comparing the asset to other volatile micro-cap tokens while debating whether to hold through current market fluctuations.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is currently in the spotlight as the company publicly refuted an activist short report that alleged fraudulent growth and channel stuffing, with many in the community arguing the claims lack credible evidence and rely on misleading interpretations of audited financials. Investors are actively discussing the stock's resilience, the potential for a short squeeze, and the firm's strong underlying growth trajectory, while urging management to maintain proactive communication to reassure shareholders against further volatility.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investor attention intensifies around the company's aggressive M&A strategy to fortify its oncology pipeline ahead of the 2028 patent expiration for its blockbuster drug, Keytruda. The community is actively discussing potential acquisition targets, the implications of its recent decision to end buyout talks with Revolution Medicines, and how new strategic business units will manage upcoming patent cliffs.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing heightened interest as investors weigh its pivot toward high-margin AI data center chips and custom silicon against concerns over its premium valuation. The community is actively debating the company's long-term growth potential and recent performance, with many watching closely for upcoming financial results and strategic updates on its AGI CPU developments.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is experiencing a parabolic, meme-driven rally as retail investors scramble for indirect exposure to high-profile AI and tech giants like Anthropic, SpaceX, and OpenAI. While the community remains deeply divided between those capturing massive short-term gains and others warning of a looming crash due to extreme premiums over NAV and restrictive six-month lockup periods, the stock continues to trend aggressively amid limited float and heavy speculation.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors digest news of a wiring issue impacting 737 MAX deliveries, which has sparked significant debate between those seeing a prime buying opportunity in an oversold stock and others concerned about persistent quality control and management challenges. Community sentiment is deeply divided, with many actively monitoring technical support levels near $200 while speculating on potential large-scale orders from China and increased defense spending as major catalysts for a rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JRSIS Health Care Corp. engages in the operation and management of hospitals. The firm provides both Western and Chinese medical practices. It offers services in different areas including Pediatrics, Dermatology, Ear, Nose, and Throat (ENT), Traditional Chinese Medicine (TCM), Ophthalmology, Internal Medicine Dentistry, General Surgery, Rehabilitation Science, Gynecology, and General Medical Services. The company was founded on November 20, 2013 and is headquartered in Yongzhou, China.

Current Price	$0.01
Prev Close	$0.0181
Open	$0.0112
Dividend Yield	0.00%
50-Day Moving Average	$0.015
Beta	5.30
Avg. Volume	8,252.79
PE Ratio	-3.12

52-Week High	$0.10
52-Week Low	$0.0058
Market Capitalization	$845,986.00
EPS (Annual)	$0.0001
Price to Book	-4.67
Revenue Per Employee	$64,042.40

JRSS
JRSIS HEALTH CARE Corp

Feed

News

Sentiment

Fundamentals

Info

Latest JRSS News

JRSSJRSIS HEALTH CARE Corp